24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Reducing the nicotine content to make cigarettes less addictive

      research-article
      1 , 2
      Tobacco Control
      BMJ Publishing Group
      Nicotine, Addiction, Cessation

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nicotine is highly addictive and is primarily responsible for the maintenance of cigarette smoking. In 1994, Benowitz and Henningfield proposed the idea of federal regulation of the nicotine content of cigarettes such that the nicotine content of cigarettes would be reduced over time, resulting in lower intake of nicotine and a lower level of nicotine dependence. When nicotine levels get very low, cigarettes would be much less addictive. As a result, fewer young people who experiment with cigarettes would become addicted adult smokers and previously addicted smokers would find it easier to quit smoking when they attempt to do so. The regulatory authority to promulgate such a public health strategy was provided by the Family Smoking Prevention and Tobacco Control Act. Although it precludes ‘reducing nicotine to zero’, the act does not prohibit the Food and Drug Administration from setting standards for cigarette nicotine content that would prevent them from being capable of causing addiction. This paper reviews the assumptions implicit in a nicotine reduction strategy, examines the available data on the feasibility and safety of nicotine reduction, and discusses the public education, surveillance and support services that would be needed for the implementation of such a policy.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: not found
          • Article: not found

          Establishing a nicotine threshold for addiction. The implications for tobacco regulation.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.

            To examine the effects of reduced nicotine cigarettes on smoking behavior, toxicant exposure, dependence and abstinence. Randomized, parallel arm, semi-blinded study. Setting University of Minnesota Tobacco Use Research Center. Six weeks of: (i) 0.05 mg nicotine yield cigarettes; (ii) 0.3 mg nicotine yield cigarettes; or (iii) 4 mg nicotine lozenge; 6 weeks of follow-up. Measurements Compensatory smoking behavior, biomarkers of exposure, tobacco dependence, tobacco withdrawal and abstinence rate. Unlike the 0.3 mg cigarettes, 0.05 mg cigarettes were not associated with compensatory smoking behaviors. Furthermore, the 0.05 mg cigarettes and nicotine lozenge were associated with reduced carcinogen exposure, nicotine dependence and product withdrawal scores. The 0.05 mg cigarette was associated with greater relief of withdrawal from usual brand cigarettes than the nicotine lozenge. The 0.05 mg cigarette led to a significantly higher rate of cessation than the 0.3 mg cigarette and a similar rate as nicotine lozenge. The 0.05 mg nicotine yield cigarettes may be a tobacco product that can facilitate cessation; however, future research is clearly needed to support these preliminary findings.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes.

              Recent federal legislation gives the U.S. Food and Drug Administration authority to regulate the nicotine content of cigarettes. A nationwide strategy for progressive reduction of the nicotine content of cigarettes is a potential way to reduce the addictiveness of cigarettes, to prevent new smokers from becoming addicted, and to facilitate quitting in established smokers. We conducted a trial of progressive nicotine content tapering over 6 months to determine the effects on smoking behaviors and biomarkers of tobacco smoke exposure and cardiovascular effects. One hundred and thirty-five healthy smokers were randomly assigned to one of two groups. A research group smoked their usual brand of cigarettes followed by five types of research cigarettes with progressively lower nicotine content, each smoked for one month. A control group smoked their own brand of cigarettes for the same period of time. Nicotine intake, as indicated by plasma cotinine concentration, declined progressively as the nicotine content of cigarettes was reduced. Cigarette consumption and markers of exposure to carbon monoxide and polycyclic aromatic hydrocarbons, as well as cardiovascular biomarkers remained stable, whereas urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) excretion decreased. No significant changes in biomarkers of exposure or cardiovascular effects were observed in controls. Our data support the proposition that the intake of nicotine from cigarettes of smokers can be substantially lowered without increasing exposure to other tobacco smoke toxins. These findings support the feasibility and safety of gradual reduction of the nicotine content in cigarettes.
                Bookmark

                Author and article information

                Journal
                Tob Control
                Tob Control
                tobaccocontrol
                tc
                Tobacco Control
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                0964-4563
                1468-3318
                May 2013
                : 22
                : Suppl 1 , The Tobacco Endgame
                : i14-i17
                Affiliations
                [1 ]Division of Clinical Pharmacology and Experimental Therapeutics, The Departments of Medicine and Bioengineering & Therapeutic Sciences, University of California , San Francisco, California, USA
                [2 ]Department of Psychiatry and Behavioral Sciences—Behavioral Biology, The Johns Hopkins University School of Medicine, and Pinney Associates , Bethesda, Maryland, USA
                Author notes
                [Correspondence to ] Dr Neal L Benowitz, Division of Clinical Pharmacology and Experimental Therapeutics, The Departments of Medicine and Bioengineering & Therapeutic Sciences, University of California, Box 1220, San Francisco, CA 94143-1220, USA; NBenowitz@ 123456MedSFGH.ucsf.edu
                Article
                tobaccocontrol-2012-050860
                10.1136/tobaccocontrol-2012-050860
                3632983
                23591498
                40682a53-a546-40b1-9fd6-5be96dc0d15a
                Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

                This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode

                History
                : 25 October 2012
                : 14 January 2013
                : 15 January 2013
                Categories
                1506
                Endgame Proposal
                Custom metadata
                unlocked

                Public health
                nicotine,addiction,cessation
                Public health
                nicotine, addiction, cessation

                Comments

                Comment on this article